Radiation therapy

radiotherapy tolerance tests

SHORT VERSION

Radiation therapy (or radiotherapy) is a localized treatment for cancer in which ionizing radiation is delivered to cancer cells. he aim is to kill cancer cells, while sparing the surrounding healthy tissue. Almost 60% of patients with cancer will receive radiation therapy.

In 1896, one year after the discovery of X-rays by the German physicist Wilhelm Röntgen, a French doctor, Victor Despeignes, had the idea to use these X-rays to treat a stomach tumor in one of his patients. He noticed a clear decrease in the tumor volume following this treatment, which was the beginning of radiation therapy (or radiotherapy).

Today, radiotherapy is one of the three pillars of cancer treatment, with surgery and systemic treatments (chemotherapy, immunotherapy, and targeted therapies). More than half of all patients with cancer will receive radiotherapy to manage their cancer. In France, this represents almost 200,000 patients per year. Its indication depends on the cancer type and stage, and on the patient’s general healthstatus. The decision to prescribe radiotherapy is usually made at a multidisciplinary team meeting that brings together medical oncologists, radiation oncologists, surgeons, organ specialists, radiologists, nuclear medicine physicians, and pathologists.

The goal of radiation therapy (a localized treatment) is to kill cancer cells by irradiating them, while sparing the surrounding healthy tissue as much as possible.. When radiatiohttps://www.radiothera.adgency360.com/en/knowledgebase/what-is-the-principle-of-radiotherapyn is delivered to the cancer site using a machine (a linear particle accelerator) outside the body, the treatment is called external radiotherapy. When radioactive sources are implanted inside the body, to be in direct contact with the tumor, it is called brachytherapy.

In the case of external radiotherapy, the X-ray beam will pass through the skin and other tissues before reaching the tumor. The goal is to deliver the maximum dose to the tumor and to the cancer cells, while limiting the dose to the surrounding healthy tissues.

Radiotherapy hair loss

Notez cet post

FIRST TESTS TO PREDICT A PATIENT’S RADIOSENSITIVITY

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.

Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.

WHY DO A RADIOSENSITIVITY TEST?

Knowing a patient’s individual radiosensitivity is important information that can help:

  • Reassure the patient in preparation for radiotherapy
  • Guide physicians in choosing the most appropriate treatment plan
  • Adapt patient follow-up after radiotherapy

Team NovaGray

NovaGray develops radiotherapy tolerance tests for breast and prostate cancer patients. NovaGray's mission is to help personalize cancer treatment by assessing each patient's individual sensitivity before starting radiotherapy. NovaGray technology has been validated by multi-center prospective clinical trials. NovaGray tests are recommended by the French Society of Radiation Oncology (SFRO).